世界の免疫腫瘍療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Immuno-oncology Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3058
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、免疫腫瘍療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン、その他）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・免疫腫瘍療法の市場動向
・企業の競争状況、市場シェア
・免疫腫瘍療法の種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン、その他）
・免疫腫瘍療法の用途別市場規模（病院、外来手術センター、その他）
・免疫腫瘍療法の北米市場規模2016-2027（アメリカ、カナダ）
・免疫腫瘍療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・免疫腫瘍療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・免疫腫瘍療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・免疫腫瘍療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen、AstraZeneca、Bristol-Myers Squibb、Eli-Lilly、Roche、GlaxoSmithKline、Janssen Biotech、Merck、Novartis、Pfizer、Sanofi、Spectrum Pharmaceuticals、Takeda）
・結論

Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.

Market Analysis and Insights: Global Immuno-oncology Therapy Market
The global Immuno-oncology Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-oncology Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-oncology Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-oncology Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-oncology Therapy market.

Global Immuno-oncology Therapy Scope and Market Size
Immuno-oncology Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immuno-oncology Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others

Segment by Application
Hospitals
Ambulatory Surgical Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Eli-Lilly
Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-oncology Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Immuno-oncology Therapy Market Perspective (2016-2027)
2.2 Immuno-oncology Therapy Growth Trends by Regions
2.2.1 Immuno-oncology Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immuno-oncology Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Immuno-oncology Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Immuno-oncology Therapy Industry Dynamic
2.3.1 Immuno-oncology Therapy Market Trends
2.3.2 Immuno-oncology Therapy Market Drivers
2.3.3 Immuno-oncology Therapy Market Challenges
2.3.4 Immuno-oncology Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Immuno-oncology Therapy Players by Revenue
3.1.1 Global Top Immuno-oncology Therapy Players by Revenue (2016-2021)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno-oncology Therapy Revenue
3.4 Global Immuno-oncology Therapy Market Concentration Ratio
3.4.1 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2020
3.5 Immuno-oncology Therapy Key Players Head office and Area Served
3.6 Key Players Immuno-oncology Therapy Product Solution and Service
3.7 Date of Enter into Immuno-oncology Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-oncology Therapy Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Historic Market Size by Type (2016-2021)
4.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2022-2027)

5 Immuno-oncology Therapy Breakdown Data by Application
5.1 Global Immuno-oncology Therapy Historic Market Size by Application (2016-2021)
5.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Immuno-oncology Therapy Market Size (2016-2027)
6.2 North America Immuno-oncology Therapy Market Size by Type
6.2.1 North America Immuno-oncology Therapy Market Size by Type (2016-2021)
6.2.2 North America Immuno-oncology Therapy Market Size by Type (2022-2027)
6.2.3 North America Immuno-oncology Therapy Market Size by Type (2016-2027)
6.3 North America Immuno-oncology Therapy Market Size by Application
6.3.1 North America Immuno-oncology Therapy Market Size by Application (2016-2021)
6.3.2 North America Immuno-oncology Therapy Market Size by Application (2022-2027)
6.3.3 North America Immuno-oncology Therapy Market Size by Application (2016-2027)
6.4 North America Immuno-oncology Therapy Market Size by Country
6.4.1 North America Immuno-oncology Therapy Market Size by Country (2016-2021)
6.4.2 North America Immuno-oncology Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Immuno-oncology Therapy Market Size (2016-2027)
7.2 Europe Immuno-oncology Therapy Market Size by Type
7.2.1 Europe Immuno-oncology Therapy Market Size by Type (2016-2021)
7.2.2 Europe Immuno-oncology Therapy Market Size by Type (2022-2027)
7.2.3 Europe Immuno-oncology Therapy Market Size by Type (2016-2027)
7.3 Europe Immuno-oncology Therapy Market Size by Application
7.3.1 Europe Immuno-oncology Therapy Market Size by Application (2016-2021)
7.3.2 Europe Immuno-oncology Therapy Market Size by Application (2022-2027)
7.3.3 Europe Immuno-oncology Therapy Market Size by Application (2016-2027)
7.4 Europe Immuno-oncology Therapy Market Size by Country
7.4.1 Europe Immuno-oncology Therapy Market Size by Country (2016-2021)
7.4.2 Europe Immuno-oncology Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Immuno-oncology Therapy Market Size (2016-2027)
8.2 Asia-Pacific Immuno-oncology Therapy Market Size by Type
8.2.1 Asia-Pacific Immuno-oncology Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immuno-oncology Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immuno-oncology Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Application
8.3.1 Asia-Pacific Immuno-oncology Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immuno-oncology Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immuno-oncology Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Immuno-oncology Therapy Market Size by Region
8.4.1 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Immuno-oncology Therapy Market Size (2016-2027)
9.2 Latin America Immuno-oncology Therapy Market Size by Type
9.2.1 Latin America Immuno-oncology Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Immuno-oncology Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Immuno-oncology Therapy Market Size by Type (2016-2027)
9.3 Latin America Immuno-oncology Therapy Market Size by Application
9.3.1 Latin America Immuno-oncology Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Immuno-oncology Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Immuno-oncology Therapy Market Size by Application (2016-2027)
9.4 Latin America Immuno-oncology Therapy Market Size by Country
9.4.1 Latin America Immuno-oncology Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Immuno-oncology Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Immuno-oncology Therapy Market Size (2016-2027)
10.2 Middle East & Africa Immuno-oncology Therapy Market Size by Type
10.2.1 Middle East & Africa Immuno-oncology Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immuno-oncology Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immuno-oncology Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Application
10.3.1 Middle East & Africa Immuno-oncology Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immuno-oncology Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immuno-oncology Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Immuno-oncology Therapy Market Size by Country
10.4.1 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-oncology Therapy Introduction
11.1.4 Amgen Revenue in Immuno-oncology Therapy Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-oncology Therapy Introduction
11.2.4 AstraZeneca Revenue in Immuno-oncology Therapy Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-oncology Therapy Introduction
11.4.4 Eli-Lilly Revenue in Immuno-oncology Therapy Business (2016-2021)
11.4.5 Eli-Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-oncology Therapy Introduction
11.5.4 Roche Revenue in Immuno-oncology Therapy Business (2016-2021)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-oncology Therapy Introduction
11.7.4 Janssen Biotech Revenue in Immuno-oncology Therapy Business (2016-2021)
11.7.5 Janssen Biotech Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-oncology Therapy Introduction
11.8.4 Merck Revenue in Immuno-oncology Therapy Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-oncology Therapy Introduction
11.9.4 Novartis Revenue in Immuno-oncology Therapy Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-oncology Therapy Introduction
11.10.4 Pfizer Revenue in Immuno-oncology Therapy Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-oncology Therapy Introduction
11.11.4 Sanofi Revenue in Immuno-oncology Therapy Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Details
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2016-2021)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-oncology Therapy Introduction
11.13.4 Takeda Revenue in Immuno-oncology Therapy Business (2016-2021)
11.13.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Immuno-oncology Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immune Checkpoint Inhibitors
Table 4. Key Players of Immune System Modulators
Table 5. Key Players of Cancer Vaccines
Table 6. Key Players of Others
Table 7. Global Immuno-oncology Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immuno-oncology Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Immuno-oncology Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Immuno-oncology Therapy Market Share by Regions (2016-2021)
Table 11. Global Immuno-oncology Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Immuno-oncology Therapy Market Share by Regions (2022-2027)
Table 13. Immuno-oncology Therapy Market Trends
Table 14. Immuno-oncology Therapy Market Drivers
Table 15. Immuno-oncology Therapy Market Challenges
Table 16. Immuno-oncology Therapy Market Restraints
Table 17. Global Immuno-oncology Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Immuno-oncology Therapy Market Share by Players (2016-2021)
Table 19. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-oncology Therapy as of 2020)
Table 20. Ranking of Global Top Immuno-oncology Therapy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Immuno-oncology Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-oncology Therapy Product Solution and Service
Table 24. Date of Enter into Immuno-oncology Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-oncology Therapy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Immuno-oncology Therapy Revenue Market Share by Type (2016-2021)
Table 28. Global Immuno-oncology Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Immuno-oncology Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Immuno-oncology Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Immuno-oncology Therapy Revenue Market Share by Application (2016-2021)
Table 32. Global Immuno-oncology Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Immuno-oncology Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Immuno-oncology Therapy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Immuno-oncology Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Immuno-oncology Therapy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Immuno-oncology Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Immuno-oncology Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Immuno-oncology Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Immuno-oncology Therapy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Immuno-oncology Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Immuno-oncology Therapy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Immuno-oncology Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Immuno-oncology Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Immuno-oncology Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Immuno-oncology Therapy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Immuno-oncology Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Immuno-oncology Therapy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Immuno-oncology Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Immuno-oncology Therapy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Immuno-oncology Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Immuno-oncology Therapy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Immuno-oncology Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Immuno-oncology Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Immuno-oncology Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Immuno-oncology Therapy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Immuno-oncology Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Immuno-oncology Therapy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Immuno-oncology Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Immuno-oncology Therapy Product
Table 67. Amgen Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Immuno-oncology Therapy Product
Table 72. AstraZeneca Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Immuno-oncology Therapy Product
Table 77. Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Eli-Lilly Company Details
Table 80. Eli-Lilly Business Overview
Table 81. Eli-Lilly Immuno-oncology Therapy Product
Table 82. Eli-Lilly Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 83. Eli-Lilly Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Immuno-oncology Therapy Product
Table 87. Roche Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 88. Roche Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Immuno-oncology Therapy Product
Table 92. GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 93. GlaxoSmithKline Recent Development
Table 94. Janssen Biotech Company Details
Table 95. Janssen Biotech Business Overview
Table 96. Janssen Biotech Immuno-oncology Therapy Product
Table 97. Janssen Biotech Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 98. Janssen Biotech Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Immuno-oncology Therapy Product
Table 106. Novartis Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Pfizer Company Details
Table 109. Pfizer Business Overview
Table 110. Pfizer Immuno-oncology Therapy Product
Table 111. Pfizer Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 112. Pfizer Recent Development
Table 113. Sanofi Company Details
Table 114. Sanofi Business Overview
Table 115. Sanofi Immuno-oncology Therapy Product
Table 116. Sanofi Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 117. Sanofi Recent Development
Table 118. Spectrum Pharmaceuticals Company Details
Table 119. Spectrum Pharmaceuticals Business Overview
Table 120. Spectrum Pharmaceuticals Immuno-oncology Therapy Product
Table 121. Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 122. Spectrum Pharmaceuticals Recent Development
Table 123. Takeda Company Details
Table 124. Takeda Business Overview
Table 125. Takeda Immuno-oncology Therapy Product
Table 126. Takeda Revenue in Immuno-oncology Therapy Business (2016-2021) & (US$ Million)
Table 127. Takeda Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-oncology Therapy Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Immune System Modulators Features
Figure 5. Cancer Vaccines Features
Figure 6. Others Features
Figure 7. Global Immuno-oncology Therapy Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Center Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-oncology Therapy Report Years Considered
Figure 12. Global Immuno-oncology Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Immuno-oncology Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Immuno-oncology Therapy Market Share by Regions: 2020 VS 2027
Figure 15. Global Immuno-oncology Therapy Market Share by Regions (2022-2027)
Figure 16. Global Immuno-oncology Therapy Market Share by Players in 2020
Figure 17. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-oncology Therapy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Immuno-oncology Therapy Revenue in 2020
Figure 19. Global Immuno-oncology Therapy Revenue Market Share by Type (2016-2021)
Figure 20. Global Immuno-oncology Therapy Revenue Market Share by Type (2022-2027)
Figure 21. North America Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Immuno-oncology Therapy Market Share by Type (2016-2027)
Figure 23. North America Immuno-oncology Therapy Market Share by Application (2016-2027)
Figure 24. North America Immuno-oncology Therapy Market Share by Country (2016-2027)
Figure 25. United States Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Immuno-oncology Therapy Market Share by Type (2016-2027)
Figure 29. Europe Immuno-oncology Therapy Market Share by Application (2016-2027)
Figure 30. Europe Immuno-oncology Therapy Market Share by Country (2016-2027)
Figure 31. Germany Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Immuno-oncology Therapy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Immuno-oncology Therapy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Immuno-oncology Therapy Market Share by Region (2016-2027)
Figure 41. China Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Immuno-oncology Therapy Market Share by Type (2016-2027)
Figure 49. Latin America Immuno-oncology Therapy Market Share by Application (2016-2027)
Figure 50. Latin America Immuno-oncology Therapy Market Share by Country (2016-2027)
Figure 51. Mexico Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Immuno-oncology Therapy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Immuno-oncology Therapy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Immuno-oncology Therapy Market Share by Country (2016-2027)
Figure 57. Turkey Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Immuno-oncology Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 63. Eli-Lilly Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 66. Janssen Biotech Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 71. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 72. Takeda Revenue Growth Rate in Immuno-oncology Therapy Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の免疫腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Immuno-Oncology Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3059 2021年4月 96Pages
QYResearch社発行の本調査資料では、免疫腫瘍治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫チェックポイント阻害剤、モノクローナル抗体、サイトカイン免疫療法、癌ワクチン、CAR-T細胞療法）、用途別市場規模（病院、外来手術センタ...

世界のがん免疫療法市場 2021：企業別、地域別、種類・用途別

Global Immuno-oncology Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z07456 2021年4月 106Pages
当調査資料では、がん免疫療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん免疫療法の種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害薬、免疫系モジュレーター、がんワクチン、その他）、用途別市場規模（病院、外来手術センター、その他）、地...

世界の膵臓がん治療市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z4417 2021年4月 94Pages
QYResearch社発行の本調査資料では、膵臓がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物学、化学療法、標的療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の免疫腫瘍薬市場 2021：企業別、地域別、種類・用途別

Global Immuno-oncology Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z07455 2021年4月 152Pages
当調査資料では、免疫腫瘍薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。免疫腫瘍薬の種類別市場規模（免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン、腫瘍溶解性ウイルス、その他）、用途別市場規模（病院、クリニック、外来手術センター）、地域...

世界の整形外科腫瘍学市場規模・現状・予測（2021年-2027年）

Global Orthopaedic Oncology Market Size, Status and Forecast 2021-2027
QYR2104Z4331 2021年4月 94Pages
QYResearch社発行の本調査資料では、整形外科腫瘍学のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法、放射線療法、標的療法）、用途別市場規模（病院、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の整形外科腫瘍学市場規模・現状・予測（2021年-2027年）

世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Oncology Market Size, Status and Forecast 2021-2027
QYR2104Z2001 2021年4月 126Pages
QYResearch社発行の本調査資料では、腫瘍治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、免疫療法（生物学的療法）、内分泌療法、その他）、用途別市場規模（血液がん、乳がん、胃腸がん、前立腺がん、呼吸器・肺がん、そ...

世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年）

世界の放射線腫瘍市場規模・現状・予測（2021年-2027年）

Global Radiation Oncology Market Size, Status and Forecast 2021-2027
QYR2104Z4900 2021年4月 91Pages
QYResearch社発行の本調査資料では、放射線腫瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（体外照射療法（EBRT）、小線源治療）、用途別市場規模（血液がん（白血病）、乳がん、胃腸がん、呼吸器/肺がん、皮膚がん、その他のがん）、主要地...

世界の腫瘍栄養市場規模・現状・予測（2021年-2027年）

Global Oncology Nutrition Market Size, Status and Forecast 2021-2027
QYR2104Z4257 2021年4月 91Pages
QYResearch社発行の本調査資料では、腫瘍栄養のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（頭頸部がん、胃腸がん、肝臓がん、膵臓がん、食道がん、肺がん、乳がん、血液がん、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規...

世界のがん免疫療法市場 2021：企業別、地域別、種類・用途別 The Immuno-oncology Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
世界の免疫腫瘍治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Immuno-Oncology Treatment Market The global Immuno-Oncology Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
世界の免疫腫瘍薬市場 2021：企業別、地域別、種類・用途別 The Immuno-oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
世界の整形外科腫瘍学市場規模・現状・予測（2021年-2027年） Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours. Market Analysis and Insights: Global Orthopaedic Oncology Market The global Orthopaedic Oncology market size is projected to reach US$ XX million by 2…